Ampel BioSolutions (United States)

Recent papers from Ampel BioSolutions (United States)

1. The Expression of Interleukin-1β and NLRP3 Inflammasome Components in Hidradenitis Suppurativa Lesional SkinJID Innovations · 2026
2. Discovery and Structure–Activity Relationship Studies of Thienopyrroles as Group 2 Influenza A Entry InhibitorsACS Medicinal Chemistry Letters · 2026
3. Dual BAFF and APRIL inhibition with TACI-Fc depletes IgA plasma cells and ameliorates lupus nephritisiScience · 2026
4. An NT5E loss-of-function variant permits tissue inflammation and hypertension in systemic lupus erythematosusiScience · 2026
5. Subsets of Lupus Patients Identified by Gene Expression Profiles Exhibit Differential Clinical Responsiveness to BaricitinibArthritis & Rheumatology · 2026
6. Genes causative of primary immunodeficiency are risk factors for and are over-expressed in systemic lupus erythematosusFrontiers in Immunology · 2026
7. How does Elie Metchnikoff relate to the investigator of today?Annals of the Rheumatic Diseases · 2025
8. Granulocyte colony-stimulating factor protects against acute systemic alphavirus disease in a type I IFN-dependent mannerFrontiers in Immunology · 2025
9. Validation of eight endotypes of lupus based on whole-blood RNA profilesLupus Science & Medicine · 2025
10. Nociplasticity: A Proposed Concept to Understand the Symptomatology of Systemic Lupus ErythematosusArthritis & Rheumatology · 2025
11. Responsiveness of systemic lupus erythematosus subjects to iberdomide based on molecular endotypesAnnals of the Rheumatic Diseases · 2025
12. Granulocyte colony-stimulating factor protects against arthritogenic alphavirus pathogenesis in a type I IFN-dependent manner2024
13. Obesity-Associated Changes in Immune Cell Dynamics During Alphavirus Infection Revealed by Single Cell Transcriptomic Analysis2024
14. Genetic Association with Autoimmune Diseases Identifies Molecular Mechanisms of Coronary Artery DiseaseiScience · 2024
15. Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trialLupus Science & Medicine · 2024
16. The interferon-rich skin environment regulates Langerhans cell ADAM17 to promote photosensitivity in lupuseLife · 2024
17. Pos0334 Dapirolizumab Pegol Impacts Important Immunologic Pathways in Systemic Lupus Erythematosus: Pharmacodynamic Analysis of B Cell and Type I Interferon Pathways From a Phase 2b TrialAnnals of the Rheumatic Diseases · 2024
18. 404 The interferon-rich skin environment regulates Langerhans cell ADAM17 to promote photosensitivity in lupusBMJ · 2024
19. 620 Clinical management of lupus in the United States: a claims-based analysisBMJ · 2024
20. 705 Examination of the shared genetic architecture between multiple sclerosis and systemic lupus erythematosus facilitates discovery of novel lupus risk lociGenetics. · 2024